Dr. Kevin Pan was selected as a member of “113 Talent Program”

In May 2015, the government of China Medical City issued a public announcement. After qualification examination, technical review and expert panel comprehensive review, Dr. Kevin Pan, the CEO of Asieris Pharmaceuticals, was successfully selected as a member of the third group Leadership Talents of “113 Talents Program”, which means 1000 senior-level talents/teams, 100 leadership talents/teams and 3000 highly demanded talents.